Engineered enzyme against antibiotic-resistant anthrax

Written By :  Isra Zaman
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-09-15 04:00 GMT   |   Update On 2022-09-15 04:00 GMT
Advertisement
Antibiotic-resistant strains of the bacteria are of growing concern, and researchers are preparing to fight back. Now, a team reporting in ACS Infectious Diseases has taken a step toward the development of a therapeutic that can treat the infection in mice without antibiotics.
One type of B. anthracis, called the Ames strain, is particularly virulent because it can wrap itself in a protective capsule of poly-D-glutamic acid that acts like a cloak of invisibility, helping the bacteria evade the human immune system.
Advertisement
A B. anthracis enzyme called CapD anchors the capsule material to the bacteria, but previous studies have reported that the enzyme can be engineered to degrade the capsule instead, making the bacteria susceptible to the immune system.
Studies have also shown that providing mice with the engineered CapD can help treat an Ames- strain anthrax infection without the use of antibiotics. In addition, Patricia Legler and colleagues have demonstrated that adding polyethylene glycol (PEG) to this version of CapD can help the enzyme stick around longer, increasing mouse survival. In this study, the team wanted to optimize the treatment even further.
To improve the re-engineered enzyme's lifetime in the body and deliver a bigger punch, the researchers added PEG and fused the CapD protein with part of a mouse antibody. This resulted in two CapD enzymes bound together, which would essentially double its capsule- binding power.
The researchers created several versions of the enzyme and subjected them to many rounds of optimization, deleting and inserting different segments until they achieved a sequence that both held its 3D shape and performed as expected in a range of pH values. When tested in a mouse model, this construct lasted longer than the previous version without the fused antibody, though it had reduced activity.
Reference:
Patricia M. Legler et al, ACS Infectious Diseases, DOI: 10.1021/acsinfecdis.2c00227
Full View
Tags:    
Article Source : Infectious Diseases

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News